Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-02-23
2011-11-15
Havlin, Robert (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S544000
Reexamination Certificate
active
08058455
ABSTRACT:
A compound having a structure expressed by the following Structural Formula (1) and a compound having a structure expressed by the following Structural Formula (2):
REFERENCES:
patent: 2004-248596 (2004-09-01), None
patent: 2005-523258 (2005-08-01), None
patent: 2006-056787 (2006-03-01), None
patent: 98/09968 (1998-03-01), None
patent: 03/062242 (2003-07-01), None
Thompson et al. (Genome Biology 2002, 3(7):reviews1020.1-1020.4).
Tamamura et al. (STN Abstract of JP 06277084 A).
Okada et al., “Targeting two-component signal transduction: a novel drug discovery system,” Methods in Enzymology, 2007. vol. 422. pp. 386-395.
Okada et al., “Isolation of bacterial signal transduction inhibitor by selective isolation method (TS method) and action mechanism of the inhibitor.” Proceedings of Annual Meeting of Japan Society for Bioscience, Biotechnology, and Agrochemistry, 2008, vol. 2008, p. 237, lecture No. 3A I 9a10 (English translation provided).
Sievert et al., “Staphylococcus aureus resistant to vancomycin—United States, 2002,” Morbidity and Mortality Weekly Report, 2002, vol. 51, pp. 565-567.
Yamamoto et al., “New targets against drug-resistant bacteria, bacterial signal transduction,” Bioscience and Industry. 2000, vol. 58, No. 4 (English translation provided).
Fabret et al., “A two-component signal transduction system essential for growth ofBacillus subtilis: implications for anti-infective therapy,” Journal of Bacteriology, 1998, vol. 180, No. 23, pp. 6375-6383.
Martin et al.. “Role in cell permeability of an essential two-component system inStaphylococcus aureus,” Journal of Bacteriology, 1999, vol. 181, No. 12. pp. 3666-3673.
Lange et al., “Domain organization and molecular characterization of 13 two-component systems identified by genome sequencing ofStreptococcus pneumonia,” Gene, 1999, vol. 237, pp. 223-234.
Beier et al., “Molecular characterization of two-component systems of helicobacier pylori,” 2000. Journal of Bacteriology, vol. 182, No. 8, pp. 2068-2076.
Eriksson et al., Two-component regulators involved in the global control of virulence inErwinia carotovorasubsp. carotovora, Molecular Plant-Microbe Interactions, 1998, vol. 11, No. 8, pp. 743-752.
Hyytiainen et al., “The PmrA-PmrB two-component system responding to acidic pH and iron controls virulence in the plant pathogenErwinia carotovorassp. carotovora,” Molecular Microbiology, 2003, vol. 50, No. 3, pp. 795-807.
Flego et al., “A two-component regulatory system, pehR-pehS, controls endopolygalacturonase production and virulence in the plant pathogenErwinia carotovorasubsp. carotovora.” Molecular Plant-Microbe interactions. 2000. vol. 13, No. 4, pp. 447-455.
Igarashi Masayuki
Utsumi Ryutaro
Hamre Schumann Mueller & Larson P.C.
Havlin Robert
Kinki University
LandOfFree
Compound signamycin, method for production thereof, and use... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compound signamycin, method for production thereof, and use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound signamycin, method for production thereof, and use... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4305662